Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
Bookmark and Share | Print Article | Miscelaneous Frontpage Notices Previous | All Articles This Week | Next
This article originally posted and appeared in  Issue 731

TYK, May 31, 2014

Mobile App of the Week

MOVE! Coach from the VA


For your patients who are veterans, the U.S. Departments of Veterans Affairs has recently begun releasng several apps designed to both help vets in their personal health goals and also navigate the VA system. (For the complete of what's available and what's coming soon, just follow this link. You can also check out what iTunes has - the apps aren't yet available for Android yet.) MOVE! Coach is one of the first ones available and is linked in to a more comprehensive support system on their website. No reviews are in yet and there are sure to be a few bugs along the way but this is a great first step towards creating apps targeted towards the specific needs of vets. For more information.

Test Your Knowledge Question #731

Monitoring parameters for glitazones include:

a)    Liver function testing for Actos only

b)    Monitoring of sudden weight gain only in Avandia

c)    Liver function testing should be performed before the start of therapy, every 2 months for the first year, then periodically thereafter

d)    Not contraindicated in patients with NYHA Class II or IV heart failure

e)    Uric acid levels 

For the complete question and answer, just follow this link.



Bookmark and Share | Print | Category | Home

This article originally posted 23 May, 2014 and appeared in  Issue 731

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Vickie Driver, DPM, MS, FACFAS

Category: Wound Care
Credits: 1.0